Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Bombesin Receptor
    (2)
  • PACAP
    (2)
  • Others
    (2)
TargetMol | Tags By ResearchField
  • Cancer
    (2)
  • Nervous System
    (2)
  • Metabolism
    (1)
Filter
Search Result
Results for "

gastrin releasing peptide, human

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    7
    TargetMol | All_Pathways
  • Peptide Products
    7
    TargetMol | Peptide_Products
  • Antibody Products
    1
    TargetMol | Antibody_Products
Biotin-Gastrin Releasing Peptide, human
T82881
Biotin-Gastrin Releasing Peptide, human, is a biotinylated derivative of gastrin-releasing peptide (GRP), a neuropeptide known for its growth-stimulatory and tumorigenic properties [1].
  • Inquiry Price
Inquiry
Size
QTY
Biotin-Gastrin Releasing Peptide, human TFA
TP3746
Biotin-Gastrin Releasing Peptide, human TFA, is a biotinylated form of the gastrin-releasing peptide (GRP). GRP is a neuropeptide known for its growth-stimulating and tumorigenic properties.
  • Inquiry Price
Inquiry
Size
QTY
Gastrin-Releasing Peptide, human(TFA)
TP1325L
Gastrin-Releasing Peptide, human(TFA) is a regulatory human peptide that elicits gastrin release and regulates gastric acid secretion and enteric motor function. The post-ganglionic fibers of the vagus nerve that innervate the G cells of the stomach release GRP, which stimulates the G cells to release gastrin.
  • $56
In Stock
Size
QTY
TargetMol | Inhibitor Sale
GRP (human) (trifluoroacetate salt)
T36864
Gastrin-releasing peptide (GRP) is a neuropeptide that stimulates gastrin release. It binds to (Ki = 300 nM) and stimulates amylase secretion in rat pancreatic AR42J cells (EC50 = 0.3 nM). GRP increases proliferation of human liver carcinoma HepG2 and MHCC97H cells but does not affect the proliferation of normal HL-7702 liver cells at a concentration of 1 nM. In vivo, GRP (0.35 nmol/kg/h) increases both pancreatic exocrine secretion and pancreatic polypeptide (PP) release in rats. It dose-dependently stimulates gastrin, pancreatic amylase, lipase, bilirubin, and acid output and induces gallbladder contraction in humans when administered at doses ranging from 1 to 27 pmol/kg per hour.
  • $411
Inquiry
Size
QTY
PACAP (1-38)
PACAP (1-38) free acid
T81572129405-61-4
PACAP (1-38) free acid is a deamidated PACAP (1-38) derived from humans, sheep, and rats. PACAP (1-38) free acid can activate the human PAC1 receptor and promote cyclic adenosine monophosphate synthesis in NS‑1 neuroendocrine cells and non-neuroendocrine HEK293 cells.
  • $98
In Stock
Size
QTY
PACAP (1-38), human, ovine, rat TFA
Pituitary Adenylate Cyclase Activating Polypeptide 38 TFA, Pituitary Adenylate Cyclase Activating Polypeptide 38 (TFA)
TP1054
PACAP (1-38), human, ovine, rat TFA is an endogenous neuropeptide and a high-affinity agonist for the PAC1 receptor. This 38-amino acid peptide binds to the PAC1 receptor to activate adenylate cyclase, inducing an increase in intracellular cAMP levels and triggering downstream signaling. Research demonstrates that C-terminal amidation of PACAP (1-38), human, ovine, rat TFA is dispensable for its biological activity at the PAC1 receptor, with the non-amidated form retaining full agonistic potency. It plays crucial roles in neuroprotection, regulation of insulin secretion, and vasodilation.
  • $130
Inquiry
Size
QTY
Gastrin-Releasing Peptide, human
TP132593755-85-2
Gastrin-Releasing Peptide, human is a regulatory human peptide that elicits gastrin release and regulates gastric acid secretion and enteric motor function. The post-ganglionic fibers of the vagus nerve that innervate the G cells of the stomach release GRP, which stimulates the G cells to release gastrin.
  • $1,330
35 days
Size
QTY